This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO), the diabetes-and-obesity pharmaceutical leader, brought Anthropic’s Claude into its…
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO), the diabetes-and-obesity pharmaceutical leader, brought Anthropic’s Claude into its…